Restriction of hepatitis B virus replication by c-Abl–induced proteasomal degradation of the viral polymerase

Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase

(2017) Shaobing Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Proteasome inhibitors in cancer therapy

(2017) Elisabet E. Manasanch et al.   Nature Reviews Clinical Oncology

Prevention of hepatitis B virus-associated liver diseases by antiviral therapy

(2016) Akinobu Tawada et al.   Hepatology International

Cullin–RING ubiquitin E3 ligase regulation by the COP9 signalosome

(2016) Simone Cavadini et al.   NATURE

Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor

(2016) Adrien Decorsière et al.   NATURE

Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL

(2015) Ashton C. Lai et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?

(2015) Adrian M. Di Bisceglie et al.   HEPATOLOGY

Hepatitis C Virus Particle Assembly Involves Phosphorylation of NS5A by the c-Abl Tyrosine Kinase

(2015) Shota Yamauchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chronic myeloid leukaemia

(2015) Jane F Apperley   LANCET

A historical overview of protein kinases and their targeted small molecule inhibitors

(2015) Robert Roskoski   PHARMACOLOGICAL RESEARCH

CRISPR-mediated direct mutation of cancer genes in the mouse liver

(2014) Wen Xue et al.   NATURE

Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013

(2014) Hwi Young Kim   WORLD JOURNAL OF GASTROENTEROLOGY

Management of patients with hepatitis B who require immunosuppressive therapy

(2013) Jessica P. Hwang et al.   Nature Reviews Gastroenterology & Hepatology

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

(2013) J. Kronke et al.   SCIENCE

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

(2013) G. Lu et al.   SCIENCE

Medical Virology of Hepatitis B: how it began and where we are now

(2013) Wolfram H Gerlich   Virology Journal

Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor

(2013) Guan-Min Lai   WORLD JOURNAL OF GASTROENTEROLOGY

Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase

(2012) M. Garcia et al.   Science Translational Medicine

Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication

(2012) Amanda J. Hodgson et al.   VIROLOGY

Mechanism of CRL4Cdt2, a PCNA-dependent E3 ubiquitin ligase

(2011) C. G. Havens et al.   GENES & DEVELOPMENT

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein

(2011) Kasia Hrecka et al.   NATURE

Abl Family Tyrosine Kinases Regulate Sialylated Ganglioside Receptors for Polyomavirus

(2010) A. I. Swimm et al.   JOURNAL OF VIROLOGY

Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step

(2010) Brooke Harmon et al.   PLoS Pathogens

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

(2009) Teresa A. Soucy et al.   NATURE

CRL4s: the CUL4-RING E3 ubiquitin ligases

(2009) Sarah Jackson et al.   TRENDS IN BIOCHEMICAL SCIENCES

Regulated Proteolysis of DNA Polymerase η during the DNA-Damage Response in C. elegans

(2008) Seung-Hwan Kim et al.   MOLECULAR CELL

Hepatitis B viruses: Reverse transcription a different way

(2008) Michael Nassal   VIRUS RESEARCH